News Summary
Researchers at the University of Oxford have begun a six-year project called EPIONE, aimed at revolutionizing chronic pain treatment for millions. With £11 million in funding from EPSRC, the initiative merges engineering and neuroscience to develop innovative pain management technologies. Collaborative efforts include input from various experts and individuals living with chronic pain, focusing on effective solutions that are economically viable for healthcare systems.
Oxford
Scientists at the University of Oxford have initiated a groundbreaking six-year project aimed at revolutionizing treatments for chronic pain, a condition affecting approximately 28 million people in the UK. This project, entitled Effective Pain Interventions with Neural Engineering (EPIONE), is supported by an investment of £11 million, funded by the Engineering and Physical Sciences Research Council (EPSRC).
Chronic pain is a serious health issue that incurs significant costs to the NHS, estimated to be in the millions annually. The EPIONE initiative is designed to merge expertise from engineering and neuroscience fields, targeting the brain’s pain network to create new solutions for managing this pervasive issue. Researchers believe the project could lead to the development of several innovative technologies, such as a brain implant capable of sensing and responding to pain signals in real time, as well as an implantable drug delivery system that adjusts medication dosages according to the specific needs of patients.
The collaborative effort within EPIONE involves “world-leading” experts from various disciplines, including engineering, neuroscience, and clinical medicine. Importantly, the design and testing of these new interventions will include input from individuals living with chronic pain, ensuring that the solutions developed are relevant to patients’ real-life experiences and needs. Economic viability for the NHS and other healthcare systems will also be a significant focus throughout the development process of these new technologies.
In addition to Oxford, collaborating institutions on the project include the University of Cambridge, University of Glasgow, and University College London. The innovative approach taken by EPIONE moves away from traditional drug discovery methods by directly targeting the brain’s pain networks using advanced sensor systems, neuromodulation technologies, and adaptive control algorithms. The objective is to create personalized and adaptive therapies that can dynamically respond to individual patient requirements.
This public health initiative holds the potential to significantly impact millions of lives, particularly those who have not found relief through existing treatments. The project aligns with the urgency of finding effective solutions for chronic pain, which is recognized as a disease of the nervous system that can arise from errors in brain signal processing, often resulting from injuries or illnesses.
As part of the project, Amber Therapeutics, a spinout from the University of Oxford, will oversee the first clinical trials to ensure that innovative technologies are rigorously assessed for efficacy in pain management. The partnership among various institutions and disciplines distinguishes EPIONE as a forefront initiative in addressing one of the most persistent challenges within healthcare today.
The launch of this project not only underscores the commitment to advancing medical science but also illustrates a significant step forward in tackling chronic pain through collaborative, innovative research.
Deeper Dive: News & Info About This Topic
HERE Resources
Additional Resources
- Innovation News Network
- Wikipedia: Chronic pain
- The Economist
- Google Search: Chronic pain management
- The Guardian
- Google Scholar: Chronic pain treatments
